cytarabine has been researched along with Cancer of Pancreas in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (33.33) | 18.7374 |
| 1990's | 2 (7.41) | 18.2507 |
| 2000's | 9 (33.33) | 29.6817 |
| 2010's | 7 (25.93) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dimas, K; Eleutheriades, A; Foscolos, GB; Georgakopoulou, S; Khan, H; Kourafalos, VN; Mantelas, A; Mirjolet, JF; Moutsos, VI; Papanastasiou, I; Pondiki, S; Prassa, M; Riganas, S; Serin, G; Theodoropoulou, M; Tsotinis, A; Vamvakides, A; Zaniou, A | 1 |
| Fujiwara, H; Higuchi, T; Ishino, M; Iwamura, H; Kakinuma, C; Kito, N; Kuniyoshi, H; Matsumoto, T; Mima, S; Nishikawa, H; Paradiso, LJ; Saeki, K; Shimada, Y; Uematsu, R; Yamada, T | 1 |
| Dong, Z; Qin, L; Zhang, JT | 1 |
| Brody, JR; Costantino, CL; Cozzitorto, JA; Dasgupta, A; Gorospe, M; Keen, JC; Kennedy, EP; Kuwano, Y; Witkiewicz, AK; Yeo, CJ | 1 |
| Jin, J; Liu, H; Tong, HY; Wei, JY; Yu, WJ; Zhang, FJ; Zhu, WF | 1 |
| Fridley, BL; Jenkins, GD; Kalari, KR; Li, L; Lingle, W; Lou, Z; Pei, H; Petersen, G; Wang, L | 1 |
| Choi, M; Heilbrun, LK; Lawhorn-Crews, JM; Shields, AF; Venkatramanamoorthy, R; Zalupski, MM | 1 |
| Chan, S; Melia, W; Minchom, A; Shah, R | 1 |
| Adams, J; Blaszkowsky, LS; DeLaney, TF; Fernandez-Del Castillo, C; Hong, TS; Kwak, EL; Mamon, HJ; Mino-Kenudson, M; Ryan, DP; Winrich, B; Yeap, B | 1 |
| Fritzer-Szekeres, M; Golakoti, T; Graser, G; Jaeger, W; Krupitza, G; Madlener, S; Saiko, P; Schwarz, S; Somepalli, V; Szekeres, T | 1 |
| Buzello, C; Nguyen, M; Sun, D; Urrabaz, R | 1 |
| Caldera, H; Cardenas, R; Casillas, J; Servin-Abad, L | 1 |
| Adsay, V; Al-Sukhun, S; Ben-Josef, E; Forman, JD; Heilbrun, LK; Levin, K; Philip, PA; Shields, AF; Soulen, R; Vaitkevicius, VK; Weaver, D; Zalupski, MM | 1 |
| Bauman, J; Biroc, SL; Chesney, SK; Dinter, H; Ho, E; Hoffmann, J; Kirkland, T; Liu, HL; Shen, J; Subramanyam, B; Tseng, JL; Zajchowski, DA | 1 |
| Boder, GB; Grindey, GB; Hertel, LW; Houghton, JA; Houghton, PJ; Merriman, RL; Rutherford, PG; Schultz, RM; Tanzer, LR | 1 |
| Johansson, M; Karlsson, A; Permert, J; Zhu, C | 1 |
| Ahmed, S; Arlauskas, P; Du, W; Gordon, C; Kellogg, C; Shields, AF; Vaitkevicius, VK; Zalupski, MM | 1 |
| Johansson, M; Karlsson, A; Zheng, X | 1 |
| Moertel, CG | 1 |
| Arimura, GK; Russin, DJ; Yunis, AA | 1 |
| De Jager, RL; Golbey, RB; Krakoff, IH; Magill, GB | 1 |
| Hara, Y; Tobita, Y | 1 |
| Kadono, A; Masuda, M; Misawa, S; Takino, T; Yamaguchi, N | 1 |
| Botet, J; Dougherty, JB; Kelsen, D; Kemeny, N; Magill, G; Niedzwiecki, D | 1 |
| Kyriazis, AA; Kyriazis, AP; Yagoda, A | 1 |
| Hattori, T | 1 |
| Brodovsky, HS; Burke, PJ; Colsky, J; Edmonson, JH; Hall, TC; Owens, AH; Schilling, A; Shnider, BI; Wallace, HJ | 1 |
2 review(s) available for cytarabine and Cancer of Pancreas
| Article | Year |
|---|---|
Granulocytic sarcoma of the pancreas. A report of one case and review of the literature.
Topics: Adult; Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Gemtuzumab; Humans; Male; Middle Aged; Pancreatic Neoplasms; Sarcoma, Myeloid; Tomography, X-Ray Computed | 2003 |
[A review of clinical tumor immunology. An approach to immunochemotherapy].
Topics: Animals; Antibiotics, Antineoplastic; BCG Vaccine; Cytarabine; Drug Therapy, Combination; Fluorouracil; Freund's Adjuvant; Humans; Hypersensitivity, Delayed; Immunity; Immunity, Cellular; Immunoglobulins; Immunotherapy; Leukocytes; Lymphocytes; Mice; Neoplasm Regression, Spontaneous; Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms; Streptococcus; Toxins, Biological | 1974 |
5 trial(s) available for cytarabine and Cancer of Pancreas
| Article | Year |
|---|---|
Using 18F-fluorodeoxyglucose positron emission tomography to monitor clinical outcomes in patients treated with neoadjuvant chemo-radiotherapy for locally advanced pancreatic cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Monitoring; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Kaplan-Meier Estimate; Neoadjuvant Therapy; Neutrons; Pancreatectomy; Pancreatic Neoplasms; Photons; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Treatment Outcome | 2010 |
Phase I study of preoperative short-course chemoradiation with proton beam therapy and capecitabine for resectable pancreatic ductal adenocarcinoma of the head.
Topics: Aged; Aged, 80 and over; Capecitabine; Carcinoma, Pancreatic Ductal; Combined Modality Therapy; Cytarabine; Deoxycytidine; Feasibility Studies; Female; Fluorouracil; Humans; Length of Stay; Male; Middle Aged; Pancreatic Neoplasms; Pancreaticoduodenectomy; Prescriptions; Prospective Studies; Proton Therapy; Radiography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted | 2011 |
Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Caffeine; Cisplatin; Combined Modality Therapy; Cytarabine; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Pancreatic Neoplasms; Radiotherapy Dosage; Survival Analysis | 2003 |
Cisplatin, cytarabine, caffeine, and continuously infused 5-fluorouracil (PACE) in the treatment of advanced pancreatic carcinoma: a phase II study.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-19-9 Antigen; Caffeine; Cisplatin; Confidence Intervals; Cytarabine; Female; Fluorouracil; Humans; Male; Middle Aged; Neutropenia; Pancreatic Neoplasms; Phosphodiesterase Inhibitors; Remission Induction; Survival Rate; Thrombocytopenia | 2000 |
Advanced pancreatic cancer: a phase I-II trial of cisplatin, high-dose cytarabine, and caffeine.
Topics: Acute Disease; Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Caffeine; Cisplatin; Clinical Trials as Topic; Cytarabine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms; Time Factors | 1989 |
20 other study(ies) available for cytarabine and Cancer of Pancreas
| Article | Year |
|---|---|
New adamantane phenylalkylamines with σ-receptor binding affinity and anticancer activity, associated with putative antagonism of neuropathic pain.
Topics: Adamantane; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle; Cell Proliferation; Female; Humans; Male; Mice; Mice, SCID; Molecular Structure; Neuralgia; Ovarian Neoplasms; Pancreatic Neoplasms; Piperidines; Prostatic Neoplasms; Protein Binding; Receptors, sigma; Structure-Activity Relationship; Tumor Cells, Cultured | 2012 |
FF-10502, an Antimetabolite with Novel Activity on Dormant Cells, Is Superior to Gemcitabine for Targeting Pancreatic Cancer Cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cytarabine; Deoxycytidine; Gemcitabine; Humans; Molecular Targeted Therapy; Pancreatic Neoplasms | 2018 |
Reversible epigenetic regulation of 14-3-3σ expression in acquired gemcitabine resistance by uhrf1 and DNA methyltransferase 1.
Topics: 14-3-3 Proteins; CCAAT-Enhancer-Binding Proteins; Cell Line, Tumor; Cytarabine; Deoxycytidine; DNA; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Drug Resistance, Neoplasm; Epigenesis, Genetic; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Pancreatic Neoplasms; Ribonucleotide Reductases; Ubiquitin-Protein Ligases; Up-Regulation | 2014 |
The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR Up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase.
Topics: Antigens, Surface; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Cytarabine; Deoxycytidine; Deoxycytidine Kinase; Drug Resistance, Neoplasm; ELAV Proteins; ELAV-Like Protein 1; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Inactivation, Metabolic; Pancreatic Neoplasms; RNA-Binding Proteins; Time Factors; Treatment Outcome; Tumor Cells, Cultured; Up-Regulation | 2009 |
Bortezomib in treatment of extramedullary plasmacytoma of the pancreas.
Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Middle Aged; Pancreatic Neoplasms; Plasmacytoma; Pyrazines; Retreatment; Treatment Outcome; Vincristine | 2009 |
FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line; Cell Line, Tumor; Cytarabine; Docetaxel; Drug Therapy; Humans; Kidney; Neoplasms; Nuclear Proteins; Paclitaxel; Pancreatic Neoplasms; Phosphoprotein Phosphatases; Proto-Oncogene Proteins c-akt; Tacrolimus Binding Proteins; Taxoids | 2009 |
An unusual case of pancreatic cancer with leptomeningeal infiltration.
Topics: Adenocarcinoma; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Cytarabine; Drug Therapy, Combination; Fatal Outcome; Humans; Hydrocortisone; Male; Meningeal Carcinomatosis; Methotrexate; Middle Aged; Pancreatic Neoplasms | 2010 |
Combination effects of digalloylresveratrol with arabinofuranosylcytosine and difluorodeoxycytidine in human leukemia and pancreatic cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Cytarabine; Deoxycytidine; Gallic Acid; Gemcitabine; HL-60 Cells; Humans; Leukemia; Pancreatic Neoplasms; Stilbenes; Tumor Stem Cell Assay | 2011 |
Induction of DNA ligase I by 1-beta-D-arabinosylcytosine and aphidicolin in MiaPaCa human pancreatic cancer cells.
Topics: Antimetabolites, Antineoplastic; Aphidicolin; Caffeine; Cell Count; Cell Division; Cell Line; Cell Survival; Cytarabine; DNA Ligase ATP; DNA Ligases; DNA Repair; DNA-Directed DNA Polymerase; DNA, Neoplasm; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Nucleic Acid Synthesis Inhibitors; Pancreatic Neoplasms; Phosphodiesterase Inhibitors; RNA, Messenger; Tumor Cells, Cultured | 2002 |
Anti-tumor efficacy of the nucleoside analog 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl) cytosine (4'-thio-FAC) in human pancreatic and ovarian tumor xenograft models.
Topics: Animals; Carcinoma; Cytarabine; Disease Models, Animal; Female; Mice; Mice, Nude; Ovarian Neoplasms; Pancreatic Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured | 2005 |
Comparison of the antitumor activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenograft models.
Topics: Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; Colonic Neoplasms; Cytarabine; Deoxycytidine; Gemcitabine; Humans; Lung Neoplasms; Mice; Mice, Nude; Models, Biological; Molecular Structure; Pancreatic Neoplasms; Transplantation, Heterologous; Treatment Outcome | 1996 |
Enhanced cytotoxicity of nucleoside analogs by overexpression of mitochondrial deoxyguanosine kinase in cancer cell lines.
Topics: Antineoplastic Agents; Arabinonucleosides; Cladribine; Cytarabine; Deoxyguanosine; Gene Expression Regulation, Neoplastic; Green Fluorescent Proteins; Humans; Luminescent Proteins; Microscopy, Fluorescence; Mitochondria; Nucleosides; Pancreatic Neoplasms; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Recombinant Fusion Proteins; Transfection; Tumor Cells, Cultured | 1998 |
Retroviral transduction of cancer cell lines with the gene encoding Drosophila melanogaster multisubstrate deoxyribonucleoside kinase.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antiviral Agents; Arabinonucleosides; Bromodeoxyuridine; Catalysis; Cell Division; Cell Nucleus; Cladribine; Cytarabine; Deoxycytidine; Drosophila melanogaster; Gemcitabine; Humans; Inhibitory Concentration 50; Kinetics; Osteosarcoma; Pancreatic Neoplasms; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Promoter Regions, Genetic; Retroviridae; Substrate Specificity; Thymidine; Thymidine Kinase; Transduction, Genetic; Tumor Cells, Cultured | 2000 |
Clinical management of advanced gastrointestinal cancer.
Topics: Adenoma, Islet Cell; Carcinoma, Hepatocellular; Carmustine; Colonic Neoplasms; Cytarabine; Drug Therapy, Combination; Floxuridine; Fluorouracil; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Lomustine; Malignant Carcinoid Syndrome; Mitomycins; Pancreatic Neoplasms; Rectal Neoplasms; Stomach Neoplasms; Streptozocin | 1975 |
Human pancreatic carcinoma (MIA PaCa-2) in continuous culture: sensitivity to asparaginase.
Topics: Aged; Aneuploidy; Asparaginase; Carmustine; Cell Division; Cell Line; Cells, Cultured; Cytarabine; Fibrinolysis; Humans; Male; Pancreatic Neoplasms; Plasminogen; Vincristine | 1977 |
Combination chemotherapy with mitomycin C, 5-fluorouracil, and cytosine arabinoside in gastrointestinal cancer.
Topics: Adult; Aged; Cytarabine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluorouracil; Gallbladder Neoplasms; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycins; Pancreatic Neoplasms; Stomach Neoplasms | 1976 |
[Digestive tract cancer: planning of chemotherapy].
Topics: Bile Duct Neoplasms; Cytarabine; Drug Therapy, Combination; Fluorouracil; Gallbladder Neoplasms; Humans; Liver Neoplasms; Mitomycins; Pancreatic Neoplasms; Stomach Neoplasms | 1975 |
["MFC" therapy for advanced gastrointestinal cancer (author's transl)].
Topics: Cytarabine; Drug Therapy, Combination; Esophageal Neoplasms; Fluorouracil; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Mitomycins; Pancreatic Neoplasms | 1975 |
Enhanced therapeutic effect of cis-diamminedichloroplatinum(II) against nude mouse grown human pancreatic adenocarcinoma when combined with 1-beta-D-arabinofuranosylcytosine and caffeine.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Caffeine; Cisplatin; Cytarabine; Drug Synergism; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Pancreatic Neoplasms | 1985 |
A clinical evaluation of a prolonged schedule of cytosine arabinoside (NSC63878).
Topics: Adenocarcinoma; Blood Cells; Bone Marrow; Breast Neoplasms; Carcinoma; Colonic Neoplasms; Cytarabine; Female; Hematopoiesis; Humans; Leiomyosarcoma; Leukocyte Count; Liver; Lung Neoplasms; Melanoma; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Sarcoma; Ureteral Neoplasms; Urethral Neoplasms | 1970 |